Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
First Trust Financials AlphaDEX Fund
FXO
$1.13B
| $86.2M | ﹤0.01% |
1,380,442
-182,854
| -12% | -$10.9M |
|
1702
BioMarin Pharmaceuticals
BMRN
$12.6B
| $86.1M | ﹤0.01% |
1,504,989
+183,324
| +14% | +$10M |
|
|
XIFR
1703
XPLR Infrastructure LP
XIFR
$1.11B
| $85.7M | ﹤0.01% |
7,257,405
+657,408
| +10% | +$7.35M |
|
1704
Upstart Holdings
UPST
$2.96B
| $85.6M | ﹤0.01% |
2,414,712
-1,560,347
| -39% | -$48.1M |
|
1705
iShares iBonds Dec 2027 Term Treasury ETF
IBTH
$2.34B
| $85.5M | ﹤0.01% |
3,823,870
+115,868
| +3% | +$2.59M |
|
1706
Enova International
ENVA
$5.91B
| $85.5M | ﹤0.01% |
355,027
+13,120
| +4% | +$2.26M |
|
1707
iShares MSCI World ETF
URTH
$8.27B
| $85.5M | ﹤0.01% |
421,737
+55,900
| +15% | +$11.1M |
|
1708
Qualys
QLYS
$6.52B
| $85.3M | ﹤0.01% |
620,705
-25,721
| -4% | -$2.53M |
|
1709
BlackRock Taxable Municipal Bond Trust
BBN
$982M
| $85.3M | ﹤0.01% |
5,273,293
+54,648
| +1% | +$877K |
|
|
SEZL
1710
Sezzle
SEZL
$4.24B
| $85.3M | ﹤0.01% |
496,739
+29,310
| +6% | +$3.09M |
|
1711
iShares US Consumer Discretionary ETF
IYC
$1.19B
| $85.2M | ﹤0.01% |
842,331
-102,113
| -11% | -$10.3M |
|
1712
Arbutus Biopharma
ABUS
$1.02B
| $85M | ﹤0.01% |
17,698,305
-8,193,175
| -32% | -$36M |
|
1713
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.05B
| $84.8M | ﹤0.01% |
897,742
+36,605
| +4% | +$3.33M |
|
1714
Plains GP Holdings
PAGP
$5.55B
| $84.7M | ﹤0.01% |
3,489,870
-575,971
| -14% | -$13.8M |
|
1715
Scholar Rock
SRRK
$7.22B
| $84.6M | ﹤0.01% |
1,538,776
+1,319,749
| +603% | +$63.8M |
|
1716
Diageo
DEO
$51.2B
| $84.5M | ﹤0.01% |
1,051,605
+69,785
| +7% | +$5.63M |
|
|
NUVL
1717
DELISTED
Nuvalent
NUVL
| $84.1M | ﹤0.01% |
681,225
+480,435
| +239% | +$51.7M |
|
1718
iShares Core MSCI Pacific ETF
IPAC
$2.77B
| $84.1M | ﹤0.01% |
1,026,218
+31,794
| +3% | +$2.58M |
|
1719
CNO Financial Group
CNO
$5.1B
| $84M | ﹤0.01% |
1,648,544
-80,838
| -5% | -$3.76M |
|
1720
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
| $84M | ﹤0.01% |
6,934,080
+935,969
| +16% | +$11.1M |
|
1721
SS&C Technologies
SSNC
$19.6B
| $84M | ﹤0.01% |
1,353,836
+63,364
| +5% | +$4.3M |
|
1722
SSR Mining
SSRM
$7.95B
| $84M | ﹤0.01% |
2,969,745
+172,918
| +6% | +$5.27M |
|
1723
First Trust Utilities AlphaDEX Fund
FXU
$803M
| $83.9M | ﹤0.01% |
1,700,608
-171,850
| -9% | -$8.4M |
|
1724
Clean Harbors
CLH
$16.5B
| $83.9M | ﹤0.01% |
280,859
-9,470
| -3% | -$2.8M |
|
1725
Black Hills Corp
BKH
$5.6B
| $83.9M | ﹤0.01% |
1,127,193
+306,348
| +37% | +$22.6M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.